Help Shape the Future of Veterinary Education
|Articles|November 3, 2009

FDA issues alert about veterinary insulin medication

National Report -- The U.S. Food and Drug Administration (FDA) issued an alert on the possible variation in the amounts of crystalline zinc insulin contained in the formulation of Vetsulin.

National Report

-- The U.S. Food and Drug Administration (FDA) issued an alert on the possible variation in the amounts of crystalline zinc insulin contained in the formulation of Vetsulin.

FDA reports it is working with the manufacturer Intervet/Schering-Plough to monitor patients using the product. Veterinarians should watch for changes in onset or duration of activity, or any signs of hyperglycemia or hypoglycemia, FDA says. Until the matter is resolved, supplies of Vetsulin® may be limited, FDA adds, so veterinarians should consider other alternatives.

Suspected adverse events related to the drug can be reported to Intervet/Schering-Plough by calling (800) 224-5318.


Related to this article

Inside veterinary social work
In a slideshow drawn from an onsite dvm360 interview at Fetch National Harbor, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.